Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners
DEPT OF DEFENSE
Place of performance: Frederick, MD
Free. Verify your email, then we send one reminder only.
- Posted
- Jan 11, 2026
- Closes
- Oct 18, 2028 (in 825 days)
- Last verified
- Jun 10, 2026
At a glance
This is a government contract opportunity posted by DEPT OF DEFENSE in the research and development in the physical category. The deadline is October 18, 2028, 826 days from now. Work is performed in Frederick, MD.
Classification and identifiers
- Industry (NAICS)
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
- Product or service (PSC)
- National Defense R&D Services; Department of Defense - Military; Experimental Development (AC13)
- Solicitation number
- W911SR-25-S-GUIDE
- Contracting office
- W6QK ACC-APG
Who can apply
About this opportunity
W911SR-25-S-GUIDE Notice Type: Special Announcement Synopsis: This is a solicitation for parties interested in participating in projects sought by the The Joint Project Lead Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies (JPL-CBRND-EB) (JPL EB). JPL EB has the mission to accelerate the delivery of medical countermeasures to the warfighter through the development and implementation of platform systems. Generative Unconstrained Intelligence Drug Engineering (GUIDE) is an integrated computational and experimental platform designed to accelerate medical countermeasure development. GUIDE harnesses the power of advanced simulation and machine learning to enable preparedness and facilitate rapid response to protect the warfighter from a diverse and dynamic threat...